Palo Alto Investors »

Iovance Biotherapeutics shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2024-06-30 $17M 2.1M 8.02
2024-03-31 $31M 2.1M 14.82
2023-12-31 $17M 2.1M 8.13

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
BioMarin Pharmaceutical (BMRN)
Amicus Therapeutics (FOLD)
United Therapeutics Corporation (UTHR)
Biogen Idec (BIIB)
Staar Surgical Com Par $0.01 (STAA)
Alnylam Pharmaceuticals Inc Note 1.000 9/1
ACADIA Pharmaceuticals (ACAD)
Prothena Corp SHS (PRTA)
Sarepta Therapeutics (SRPT)
Anaptysbio Inc Common (ANAB)
Iovance Biotherapeutics (IOVA)
Revance Therapeutics (RVNC)
Alkermes SHS (ALKS)
Sage Therapeutics (SAGE)

View all positions for Palo Alto Investors

Top funds holding Iovance Biotherapeutics

Vanguard Group
Perceptive Advisors
MHR Fund Management
BlackRock
State Street Corporation
Soleus Capital Management
Geode Capital Management
Artisan Partners Limited Partnership
Balyasny Asset Management
Principal Financial Group
T. Rowe Price Associates
Jpmorgan Chase & Co
Morgan Stanley
Goldman Sachs Group
Susquehanna International

View all funds holding Iovance Biotherapeutics